Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_assertion type Assertion NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_head.
- NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_provenance.
- NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_assertion evidence source_evidence_literature NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_provenance.
- NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_assertion SIO_000772 20488920 NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_provenance.
- NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_assertion wasDerivedFrom befree-20140225 NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_provenance.
- NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_assertion wasGeneratedBy ECO_0000203 NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_provenance.